A5063374109- COVID-19 and Mental Health
- Long-Term Effects of COVID-19
- Ethics in Clinical Research
- Diabetes Treatment and Management
- Heart Failure Treatment and Management
- Psoriasis: Treatment and Pathogenesis
- Mental Health Research Topics
- Pharmaceutical Practices and Patient Outcomes
- Potassium and Related Disorders
- Health Systems, Economic Evaluations, Quality of Life
- Digital Mental Health Interventions
- Privacy-Preserving Technologies in Data
Aetion (United States)
2023-2024
National Institute of Mental Health
2020-2021
Abstract Aims The United Nations warned of COVID-19-related mental health crisis; however, it is unknown whether there an increase in the prevalence disorders as existing studies lack a reliable baseline analysis or they did not use diagnostic measure. We aimed to analyse trends prior and during COVID-19 pandemic. Methods analysed data from repeated cross-sectional surveys on representative sample non-institutionalised Czech adults (18+ years) both November 2017 ( n = 3306; 54% females) May...
Background: The United Nations warned of COVID-19 related mental health crisis; however, it is unknown whether there an increase in prevalence disorders as existing studies lack a reliable baseline analysis. We aimed to analyse trends the prior and during pandemic. Methods: analysed data from repeated cross-sectional surveys on representative sample non-institutionalized Czech adults (18 64 years) both 2017 2020. used Mini International Neuropsychiatric Interview (MINI) main screening...
Abstract Currently, the utilization patterns of medications for heart failure (HF) after worsening HF events remain unelucidated in Japan. Here, we conducted a retrospective cohort study evaluating changes drug 6 months before and hospitalizations HF. The adherence to newly initiated was evaluated based on proportion days covered (PDC) persistence as continuous treatment episodes among new users. included 9091 patients hospitalized between January 2016 September 2019, including 2735 (30.1%)...
Among patients with psoriasis (PSO), the diagnosis and treatment patterns of psoriatic arthritis (PsA) differ depending on managing-physician's specialty. ObjectivesTo estimate incidence of, time to, factors associated PsA after incident PSO diagnosis.To evaluate disease management pattern, by physician specialty, 1 year before among PsA. Methods• Data were extracted from HealthVerity Claims, Pharmacy, Electronic Medical Record (EMR) database, November 2015-August 2022, for insured (≥18...